Dr Charlie Franck Amoia is a Lecturer-Researcher in Immunology at the Faculty of Sciences and Technology, University Alassane Ouattara, in Côte d'Ivoire. He holds a PhD in Veterinary Medicine, with a specialization in Molecular Virology, Immunology, and Vaccinology, from Sokoine University of Agriculture in Tanzania.
His research focuses on vaccine development against viral pathogens. As a Visiting Scholar at the Weger-Lucarelli Laboratory at Virginia Tech (USA), he designed and developed a genotype-matched, adjuvanted DNA vaccine against Newcastle Disease Virus (NDV), a highly contagious avian paramyxovirus that causes severe acute respiratory disease in poultry, with up to 100% mortality in unvaccinated flocks. This vaccine demonstrated strong protective efficacy in animal models. Most recently, as a Junior Research Investigator at the SACIDS Foundation for One Health in Tanzania, Dr. Amoia led the field evaluation of that same vaccine candidate.
He is an active Early Career Researcher member of the International Veterinary Vaccinology Network and is deeply committed to translating cutting-edge immunology and vaccinology into practical, life-saving solutions for viral threats in Africa and beyond.
